Compare BLLN & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | CALM |
|---|---|---|
| Founded | 2016 | 1957 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | N/A | 1996 |
| Metric | BLLN | CALM |
|---|---|---|
| Price | $80.12 | $77.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $129.57 | $93.25 |
| AVG Volume (30 Days) | 318.7K | ★ 728.9K |
| Earning Date | 03-04-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 10.67% |
| EPS Growth | N/A | ★ 338.49 |
| EPS | N/A | ★ 6.26 |
| Revenue | N/A | ★ $1,351,609,000.00 |
| Revenue This Year | $45.89 | N/A |
| Revenue Next Year | $30.17 | N/A |
| P/E Ratio | ★ N/A | $12.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.96 | $71.92 |
| 52 Week High | $138.70 | $126.40 |
| Indicator | BLLN | CALM |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 29.85 |
| Support Level | $63.98 | $71.92 |
| Resistance Level | $86.01 | $90.52 |
| Average True Range (ATR) | 5.61 | 2.65 |
| MACD | 1.30 | -1.34 |
| Stochastic Oscillator | 75.47 | 3.21 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.